Hutch News

Hutch News

Stories tagged 'global oncology'

Lab advance brings a closer look at cancer in Africa

Live cancer cells travel 8,800 miles for deep analyses in Seattle

Oct. 23, 2018 | By Sabin Russell / Fred Hutch News Service

Researchers in Fred Hutch's Global Oncology program have developed a protocol to ship live Kaposi sarcoma tumor samples to Seattle for analyses with state-of-the-art equipment.

View story >


UCI-Fred Hutch collaboration turns 10

In Uganda, innovation and persistence allow a 'sustainable cancer program' to take root

June 12, 2018 | By Mary Engel / Fred Hutch News Service

In Uganda, innovation and persistence allow a "sustainable cancer program" to take root.

View story >


Fellowship program for next generation of oncologists launches in Uganda

New model for global oncology training is a partnership between Fred Hutch, University of Washington, Uganda Cancer Institute — and more

May 4, 2018

A video and article about the launch of the East African Adult Hematology-Oncology Fellowship Program, which will bring Fred Hutch and UW Medicine oncologists to Uganda to train the next generation of East African oncologists.

View story >


First human antibody found to block Epstein-Barr virus

Early research could open new path for vaccine against EBV-related cancers, mononucleosis

April 17, 2018 | By Mary Engel / Fred Hutch News Service

The finding opens a new path to developing a vaccine against EBV, a virus best known for causing mono but which is associated with about 200,000 cancer cases a year.

View story >


Meet Global Oncology's deputy program head

Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health

Feb. 22, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Thomas Uldrick brings expertise in HIV-related cancers and experience in — and a passion for — developing clinical trials to his new position at Fred Hutch Global Oncology.

View story >


For cancer patients with HIV, immunotherapy appears safe

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials

Nov. 7, 2017 | By Mary Engel / Fred Hutch News Service

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.